Congenital hyperinsulinism.
Congenital hyperinsulinism is a cause of persistent hypoglycaemia in the neonatal period. It is a heterogeneous disease with respect to clinical presentation, molecular biology, genetic aetiology and response to medical therapy. The clinical heterogeneity may range from severe life-threatening disease to very mild clinical symptoms. Recent advances have begun to clarify the molecular pathophysiology of this disease, but despite these advances treatment options remain difficult and there are many long-term complications. So far mutations in five different genes have been identified in patients with congenital hyperinsulinism. Most cases are caused by mutations in genes coding for either of the two subunits of the beta-cell K(ATP) channel (ABCC8 and KCNJ11). Two histological subtypes of the disease - diffuse and focal - have been described. The preoperative histological differentiation of these two subtypes is now mandatory as surgical management will be radically different. The ability to distinguish diffuse from focal lesions has profound implications for therapeutic approaches, prognosis and genetic counselling.
Hussain
K
K
The Institute of Child Health, Unit of Biochemistry, Endocrinology and Metabolism, University College London, 30 Guilford Street, London WC1N 1EH, UK. k.hussain@ich.ucl.ac.uk
D000818:Animals; D017209:Apoptosis; D044903:Congenital Hyperinsulinism / Q000175:diagnosis / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D005941:Glucokinase / Q000235:genetics / Q000378:metabolism; D005969:Glutamate Dehydrogenase / Q000235:genetics / Q000378:metabolism; D006801:Humans; D019656:Loss of Heterozygosity; D051379:Mice; D009154:Mutation; D015221:Potassium Channels / Q000737:chemistry / Q000235:genetics
D015221:Potassium Channels; D005969:Glutamate Dehydrogenase; D005941:Glucokinase